Find link

language:

jump to random article

Find link is a tool written by Edward Betts.

searching for Decoy receptors 547 found (779 total)

alternate case: decoy receptors

Ascrinvacumab (37 words) [view diff] exact match in snippet view article find links to article

Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Transforming growth interacting factor (73 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
RTK class III (66 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Lerdelimumab (84 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Somatomedin receptor (60 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Lenograstim (149 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Activin type 1 receptors (143 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
T-cell growth factor (228 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Molgramostim (120 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Transforming growth factor (596 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
FGF20 (221 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Activin receptor (174 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
FGF22 (203 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Alacizumab pegol (35 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Colony-stimulating factor (374 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Keratinocyte growth factor (182 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Ciliary neurotrophic factor receptor (146 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Duligotuzumab (87 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
FGF15/19 (257 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
I-SMAD (63 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Futuximab (127 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Seribantumab (124 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Emibetuzumab (117 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Imgatuzumab (124 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Metelimumab (310 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Epigen (201 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Fasinumab (142 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Bone morphogenetic protein receptor (329 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Patritumab (160 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Dusigitumab (89 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Ganitumab (130 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Glia maturation factor (115 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Flanvotumab (59 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Icrucumab (139 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Persephin (394 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Tovetumab (150 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
GFRA4 (80 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Rilotumumab (127 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Foretinib (183 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Nesvacumab (170 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Necitumumab (199 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Ertumaxomab (118 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Insulin-like growth factor-binding protein (468 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Ficlatuzumab (173 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Neuregulin 4 (413 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Norwogonin (174 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Sargramostim (876 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Robatumumab (178 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
7,8,3'-Trihydroxyflavone (249 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Figitumumab (298 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
GFRA3 (644 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Angiopoietin receptor (224 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Fulranumab (205 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Promegapoietin (181 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Neuregulin 2 (726 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Diosmetin (145 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Grandinin (363 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Mubritinib (141 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Onartuzumab (424 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Linsitinib (286 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
FGF6 (606 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Tumor necrosis factor superfamily (316 words) [view diff] exact match in snippet view article find links to article
superfamily modulators LTB (TNFβ) Agonists: Lymphotoxin (α (TNFβ), β (TNFC)) Decoy receptors: Baminercept TNF (TNFα) Others TNF superfamily protein ligands: 4-1BBL
Fresolimumab (381 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Deoxygedunin (653 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Becaplermin (418 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
K252a (282 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Thrombopoietin (1,066 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
R13 (drug) (261 words) [view diff] exact match in snippet view article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Growth factor receptor (591 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
CSPG5 (456 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
LEFTY2 (237 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
FGF3 (790 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
SB-431542 (399 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Tavilermide (381 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Radotinib (296 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Rociletinib (122 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Ancestim (257 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Cenegermin (282 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
LM22A-4 (300 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Eutropoflavin (334 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
PDGFB (434 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Bone morphogenetic protein 8A (282 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Lipegfilgrastim (435 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Dalotuzumab (624 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Canertinib (241 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Ephrin A3 (684 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Mecasermin (272 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
INHBC (490 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Enasidenib (417 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
FGF11 (171 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Semaxanib (543 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Masitinib (608 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Ephrin A4 (667 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Dacomitinib (294 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Toceranib (281 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
IGFBP6 (973 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
GDF1 (566 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Ephrin A2 (714 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
IGFBP2 (887 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Trofinetide (793 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Icotinib (668 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Dacomitinib (294 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Toceranib (281 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
GDF7 (465 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
MST1 (901 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Trafermin (249 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Hepatoma-derived growth factor (900 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
ANA-12 (562 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
R7 (drug) (692 words) [view diff] exact match in snippet view article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Olaratumab (913 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Neuregulin (867 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Cerebrolysin (1,049 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
ANGPT4 (679 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
GFRA2 (gene) (812 words) [view diff] exact match in snippet view article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Cixutumumab (617 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Zalutumumab (806 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Activin type 2 receptors (583 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Cyclotraxin B (301 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Mothers against decapentaplegic homolog 5 (240 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Cediranib (644 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Infigratinib (777 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Lestaurtinib (1,576 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
IGFBP4 (1,224 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
FGF16 (275 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
FMS-like tyrosine kinase 3 ligand (724 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Evinacumab (683 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Ephrin B1 (1,097 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
FGF7 (1,231 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Lenvatinib (934 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
PDGFD (793 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
IGFBP5 (904 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Artemin (1,184 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Bone morphogenetic protein 10 (529 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Motesanib (956 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Trk receptor (3,128 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
VEGF receptor (755 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
TNF receptor superfamily (501 words) [view diff] exact match in snippet view article find links to article
superfamily modulators LTB (TNFβ) Agonists: Lymphotoxin (α (TNFβ), β (TNFC)) Decoy receptors: Baminercept TNF (TNFα) Others TNF superfamily protein ligands: 4-1BBL
Murodermin (80 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Growth differentiation factor (1,271 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
HIOC (369 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Dihexa (572 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Thrombopoietin receptor (1,526 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Ephrin A1 (860 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Lymphotoxin (1,459 words) [view diff] exact match in snippet view article find links to article
superfamily modulators LTB (TNFβ) Agonists: Lymphotoxin (α (TNFβ), β (TNFC)) Decoy receptors: Baminercept TNF (TNFα) Others TNF superfamily protein ligands: 4-1BBL
Lymphotoxin beta (1,494 words) [view diff] exact match in snippet view article find links to article
superfamily modulators LTB (TNFβ) Agonists: Lymphotoxin (α (TNFβ), β (TNFC)) Decoy receptors: Baminercept TNF (TNFα) Others TNF superfamily protein ligands: 4-1BBL
Fibroblast growth factor receptor (827 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
MST1R (1,088 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
R-SMAD (304 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Des(1-3)IGF-1 (346 words) [view diff] exact match in snippet view article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Fibroblast growth factor receptor (827 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Bone morphogenetic protein 8B (600 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
MST1R (1,088 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Nimotuzumab (803 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
TGF beta receptor 2 (960 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Pegfilgrastim (844 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
FGF15 (748 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Des(1-3)IGF-1 (346 words) [view diff] exact match in snippet view article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Larotrectinib (585 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Growth factor (1,131 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Gossypetin (263 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Regorafenib (853 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Ramucirumab (1,289 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
GDF10 (590 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Tanezumab (644 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Lymphotoxin beta receptor (1,508 words) [view diff] exact match in snippet view article find links to article
superfamily modulators LTB (TNFβ) Agonists: Lymphotoxin (α (TNFβ), β (TNFC)) Decoy receptors: Baminercept TNF (TNFα) Others TNF superfamily protein ligands: 4-1BBL
INHA (1,000 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
TGF beta signaling pathway (2,098 words) [view diff] exact match in snippet view article find links to article
or negatively, including the agonists for ligands and R-SMADs, the decoy receptors, and the ubiquitination of R-SMADs and receptors. Both chordin and
Mothers against decapentaplegic homolog 1 (468 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
IGFBP1 (1,045 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Matuzumab (842 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Mirvetuximab soravtansine (790 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
BMPR1B (524 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Ephrin A5 (1,211 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
GDF3 (900 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Mothers against decapentaplegic homolog 9 (369 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
BAMBI (930 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
ANGPT2 (1,113 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
N-Acetylserotonin (1,142 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Olmutinib (365 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
ACVR1C (896 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Avapritinib (1,046 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Ephrin B2 (1,320 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
EPHA6 (649 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Bosutinib (594 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Tyrosine kinase inhibitor (1,081 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Gremlin (protein) (1,490 words) [view diff] exact match in snippet view article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Transforming growth factor beta superfamily (595 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
BNN-20 (572 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Sorafenib (2,617 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Adrenomedullin (1,432 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
LTBP1 (gene) (1,023 words) [view diff] exact match in snippet view article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
GDF6 (1,278 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
GFRA1 (1,493 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Vandetanib (1,148 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Epiregulin (1,149 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
C-fos-induced growth factor (1,253 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
ACVR2A (1,427 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Teprotumumab (1,041 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
EPH receptor A1 (622 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Ripretinib (1,128 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Quizartinib (1,251 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Lefty (protein) (1,327 words) [view diff] exact match in snippet view article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
C-fos-induced growth factor (1,253 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
ACVR2B (1,346 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Renalase (1,789 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
CTGF (1,537 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
EPHB6 (719 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Tivozanib (1,189 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
GDF15 (1,339 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Oncomodulin (1,183 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
PDGFA (1,108 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
EPH receptor B2 (614 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
INHBA (1,109 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
BNN-27 (615 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Neurturin (1,477 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
PDGFC (1,369 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Tumor necrosis factor receptor 2 (1,356 words) [view diff] exact match in snippet view article find links to article
superfamily modulators LTB (TNFβ) Agonists: Lymphotoxin (α (TNFβ), β (TNFC)) Decoy receptors: Baminercept TNF (TNFα) Others TNF superfamily protein ligands: 4-1BBL
ACVR1B (1,542 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
FGF12 (639 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Tropomyosin receptor kinase C (3,936 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
EPH receptor A5 (703 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
CSF2RB (192 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Neratinib (1,299 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
TGF beta 2 (910 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Ephrin B3 (1,023 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
EPHA8 (783 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Filgrastim (1,645 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
FGF10 (1,338 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
EPHB3 (933 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Interleukin 34 (283 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Insulin-like growth factor (1,689 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
ACVR1 (1,052 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Axitinib (1,126 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Poly(A)-specific ribonuclease (1,338 words) [view diff] exact match in snippet view article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
GDF5 (1,063 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Binimetinib (1,079 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Lorlatinib (914 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
IGF-1 LR3 (412 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Vascular endothelial growth factor B (1,558 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Sprifermin (532 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
EPHA7 (711 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Mecasermin rinfabate (1,227 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Panitumumab (1,421 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
TGF beta receptor 1 (1,618 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Pleiotrophin (1,649 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Osimertinib (1,489 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
TGF-beta receptor family (468 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Palifermin (1,288 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Mothers against decapentaplegic homolog 6 (1,283 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Mothers against decapentaplegic homolog 6 (1,283 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Palifermin (1,288 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
FGF9 (1,756 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Pralsetinib (934 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
BMPR2 (1,160 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Fibroblast growth factor 23 (1,854 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Capmatinib (1,217 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Kinase insert domain receptor (794 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Bone morphogenetic protein 15 (1,674 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
INHBB (1,551 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
EPH receptor B4 (731 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Trastuzumab/hyaluronidase (703 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
EPH receptor A3 (1,046 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Tepotinib (935 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Neurotrophic factor receptor (670 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
EPH receptor B1 (1,109 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Tucatinib (1,683 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Platelet-derived growth factor receptor (1,563 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Follistatin (2,169 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Nilotinib (1,667 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Erythropoietin (3,413 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Pegaptanib (1,231 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Trametinib (991 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Bone morphogenetic protein 2 (1,370 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
ERBB4 (1,597 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Cobimetinib (1,016 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
TGF beta receptor (334 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Type I cytokine receptor (514 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Type II cytokine receptor (616 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Ceritinib (1,239 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Trastuzumab deruxtecan (2,053 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Bone morphogenetic protein 6 (1,159 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Pituitary adenylate cyclase-activating peptide (1,728 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Lapatinib (1,479 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
ADCYAP1R1 (1,555 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Decorin (1,949 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Cabozantinib (1,649 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Crizotinib (1,845 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
FGF14 (879 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Bone morphogenetic protein 5 (1,025 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
BMPR1A (1,490 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Betacellulin (1,755 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Selpercatinib (1,848 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
EPH receptor A4 (766 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
GFRα (109 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
FGF4 (2,075 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
CALCRL (1,689 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Asciminib (1,212 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
ACVRL1 (1,797 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Erlotinib (1,993 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Angiopoietin 1 (1,623 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Fibroblast growth factor 8 (2,175 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Fibroblast growth factor receptor 4 (1,289 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
EPH receptor A2 (1,340 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Selpercatinib (1,848 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
FGF4 (2,075 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Afatinib (1,126 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Neurotrophin-3 (1,816 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Asciminib (1,212 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
FGF18 (2,153 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Tumor necrosis factor receptor 1 (2,200 words) [view diff] exact match in snippet view article find links to article
superfamily modulators LTB (TNFβ) Agonists: Lymphotoxin (α (TNFβ), β (TNFC)) Decoy receptors: Baminercept TNF (TNFα) Others TNF superfamily protein ligands: 4-1BBL
Insulin-like growth factor 2 receptor (1,664 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
TGF alpha (2,040 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Entrectinib (2,105 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Ciliary neurotrophic factor (1,740 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Gefitinib (2,150 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Ephrin (2,476 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Crenolanib (2,060 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Transforming growth factor, beta 3 (1,815 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Amivantamab (1,692 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Daved H. Fremont (329 words) [view diff] exact match in snippet view article find links to article
interactions between host cytokines and poxviruses and herpesviruses decoy receptors and neutralization of West Nile virus by therapeutic antibodies. Fremont
IGFBP7 (2,499 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Fibroblast growth factor receptor 3 (1,955 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Decoy receptor 1 (992 words) [view diff] exact match in snippet view article find links to article
"Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors". Science. 277 (5327): 818–21. doi:10.1126/science.277.5327.818. PMID 9242611
Alectinib (1,424 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Decoy receptor 2 (917 words) [view diff] exact match in snippet view article find links to article
et al. (2000). "Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma
Growth factor receptor inhibitor (381 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Midkine (2,372 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Dasatinib (1,994 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Endoglin (2,839 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
FGF19 (2,570 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
EPHA10 (138 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Epidermal growth factor (1,735 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Pemigatinib (1,497 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
TGFBR3 (1,632 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
RET proto-oncogene (2,385 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Activin and inhibin (2,557 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Cetuximab (2,542 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Ponatinib (1,623 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Erythropoietin receptor (3,408 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Pertuzumab (2,121 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Insulin-like growth factor 2 (1,928 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Fibroblast growth factor (3,123 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Sunitinib (3,403 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
GDNF family of ligands (1,125 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Interleukin receptor (248 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Platelet-derived growth factor (2,877 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Hepatocyte growth factor (2,711 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Faralimomab (76 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Noggin (protein) (2,327 words) [view diff] exact match in snippet view article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Thrombospondin 1 (2,343 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Brolucizumab (1,105 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Mothers against decapentaplegic homolog 2 (1,925 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Interleukin-28 receptor (1,126 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Receptor activity-modifying protein (529 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Nerve growth factor (2,786 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
GDF2 (2,618 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Fletikumab (117 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Neuregulin 3 (2,559 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Amphiregulin (3,296 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Perakizumab (67 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Hemopoietic growth factor (544 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Fibroblast growth factor receptor 2 (1,748 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Vascular endothelial growth factor C (3,104 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Neurotrophic factors (1,784 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
KIT (gene) (4,118 words) [view diff] exact match in snippet view article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Vemurafenib (1,808 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
ErbB (2,736 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Encorafenib (721 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Nodal homolog (2,488 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Ranibizumab (2,776 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Interferon alfacon-1 (30 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Inolimomab (137 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
TGF beta 1 (2,290 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
IFNA6 (372 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
IFNA5 (407 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Cardiotrophin 1 (168 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
IFNA14 (478 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
IFNA10 (459 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Receptor tyrosine kinase (3,078 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
IFNA21 (410 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Bone morphogenetic protein 7 (2,565 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Glial cell line-derived neurotrophic factor (2,730 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Interleukin-31 receptor (36 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Thrombopoietin mimetics (76 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Tucotuzumab celmoleukin (65 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Monokine (133 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Basic fibroblast growth factor (2,693 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Neurotrophin (3,069 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Interleukin-22 receptor (95 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Mothers against decapentaplegic homolog 7 (2,851 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Interleukin-11 receptor (111 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Selumetinib (2,184 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Tropoflavin (2,225 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Anrukinzumab (55 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Faricimab (1,543 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Lymphokine (184 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Heparin-binding EGF-like growth factor (2,596 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Bone morphogenetic protein (3,436 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Dabrafenib (1,122 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Proteoglycan 4 (3,645 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Rontalizumab (105 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Mothers against decapentaplegic homolog 7 (2,851 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Pascolizumab (148 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Sifalimumab (141 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Trastuzumab emtansine (2,699 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Tropomyosin receptor kinase A (3,264 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Selumetinib (2,184 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Interferon alpha-n3 (28 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
IFNA17 (558 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Lymphotoxin alpha (2,853 words) [view diff] exact match in snippet view article find links to article
superfamily modulators LTB (TNFβ) Agonists: Lymphotoxin (α (TNFβ), β (TNFC)) Decoy receptors: Baminercept TNF (TNFα) Others TNF superfamily protein ligands: 4-1BBL
IFNA4 (524 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
IFNW1 (589 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Fezakinumab (176 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Integrin (3,930 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Angiopoietin (2,150 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Elsilimomab (181 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Fontolizumab (144 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Glucose-6-phosphate isomerase (3,057 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
ERBB3 (2,750 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Clazakizumab (153 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Sirukumab (262 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Vascular endothelial growth factor A (3,053 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
IFNA8 (451 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Interleukin-18 receptor (183 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
TRAIL (1,335 words) [view diff] exact match in snippet view article find links to article
that have variable affinity for different death (DR4 and DR5) and decoy receptors (DCR1 and DCR2) may allow selective targeting of cancer cells by controlling
Growth differentiation factor-9 (3,324 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
FGF1 (2,307 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Interleukin-12 receptor (156 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Varlilumab (183 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Peficitinib (173 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Denileukin diftitox (237 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Ingenol mebutate (1,294 words) [view diff] exact match in snippet view article find links to article
after treatment with ingenol mebutate. In addition, the interleukin decoy receptors IL1R2 and IL13RA2 were induced, resulting in a reduction in the long-term
CD153 (102 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Fibroblast growth factor receptor-like 1 (842 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Interleukin-27 receptor (269 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Cerberus (protein) (2,730 words) [view diff] exact match in snippet view article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Insulin-like growth factor 1 receptor (3,603 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Nintedanib (3,010 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Pegsunercept (143 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
SMAD (protein) (4,581 words) [view diff] exact match in snippet view article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Ephrin receptor (3,454 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Midostaurin (567 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Namilumab (276 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Pacritinib (315 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
PDGFRB (3,403 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Tesevatinib (381 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Neuregulin 1 (3,921 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
IFNA7 (876 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
PDGFRB (3,403 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Mothers against decapentaplegic homolog 4 (3,464 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Tesevatinib (381 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Vascular endothelial growth factor (4,578 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Mothers against decapentaplegic homolog 3 (4,173 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
RAMP2 (1,169 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Low-affinity nerve growth factor receptor (4,235 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Tropomyosin receptor kinase B (4,321 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
RAMP1 (1,146 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Interleukin-3 receptor (206 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
IL17RC (463 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
TNF receptor associated factor (136 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
IGFBP3 (4,717 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Brain-derived neurotrophic factor (5,339 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
C-Met inhibitor (3,549 words) [view diff] exact match in snippet view article find links to article
steps that regulate c-Met activation by antibodies, peptide agonists, decoy receptors and other biologic inhibitors or small molecules inhibitors. The c-Met
Epoetin theta (222 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Fibroblast growth factor 21 (3,036 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
GDF11 (3,974 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Fas ligand (2,581 words) [view diff] exact match in snippet view article find links to article
ISSN 0883-0185. PMID 10626245. Sheikh MS, Fornace AJ (2000). "Death and decoy receptors and p53-mediated apoptosis". Leukemia. 14 (8): 1509–1513. doi:10.1038/sj
Tyrosine kinase (5,251 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Brodalumab (628 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
RAMP3 (1,066 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Insulin-like growth factor 1 (4,741 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Vorsetuzumab mafodotin (116 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Gevokizumab (211 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Cytokine receptor (442 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Adipokine (443 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Janus kinase (974 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
HER2 (4,641 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Glycoprotein 130 (2,202 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Dehydroepiandrosterone sulfate (2,570 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Deucravacitinib (694 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Interferon gamma receptor 2 (245 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Platelet-derived growth factor receptor A (3,354 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Atiprimod (345 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
CD120 (337 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Siltuximab (852 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Interleukin-7 receptor (550 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Epoetin beta (326 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Interleukin-15 receptor (690 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Benralizumab (267 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Guselkumab (1,017 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Basiliximab (587 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Interleukin 28 (721 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Interferon alfa (654 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
IL22RA1 (627 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Prasterone sulfate (534 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Fibroblast growth factor receptor 1 (5,001 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Briakinumab (551 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
CCRL2 (517 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Interleukin 28 (721 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Lebrikizumab (716 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
IFNB1 (857 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Romiplostim (542 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Interleukin-5 receptor (848 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Anti-Müllerian hormone (4,885 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Rilonacept (415 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Imatinib (6,513 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
IFNA16 (1,013 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Amitriptyline/perphenazine (554 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
IFNA13 (1,005 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Sarilumab (1,182 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
IL36A (918 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Pertuzumab/trastuzumab/hyaluronidase (958 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Interleukin 20 receptor, beta subunit (677 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Anifrolumab (826 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
IL36B (844 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Interleukin 5 (1,478 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
TNFSF9 (667 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Interleukin 27 receptor, alpha subunit (668 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Tumor necrosis factor (6,302 words) [view diff] exact match in snippet view article find links to article
superfamily modulators LTB (TNFβ) Agonists: Lymphotoxin (α (TNFβ), β (TNFC)) Decoy receptors: Baminercept TNF (TNFα) Others TNF superfamily protein ligands: 4-1BBL
Interleukin-8 receptor (963 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Interleukin-20 receptor (829 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Peginesatide (572 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Secukinumab (1,152 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Albinterferon (404 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Myostatin (5,322 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Interleukin 36 receptor antagonist (1,151 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Trastuzumab (5,895 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
IL18BP (942 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
IL17RB (728 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
IL18RAP (717 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Dehydroepiandrosterone (3,935 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Enavatuzumab (103 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Alpha-taxilin (1,060 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Interleukin-4 receptor (774 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Fruquintinib (524 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Wnt signaling pathway (7,427 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
CD70 (1,089 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Interferon-gamma receptor (868 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Interleukin 31 (1,120 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Pitrakinra (780 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
IL-2 receptor (934 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
IL1RL2 (603 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Death receptor 4 (1,026 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Canakinumab (1,263 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Interleukin 32 (802 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Ectodysplasin A2 receptor (525 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Interleukin-21 receptor (864 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin